Market Tracker

07/31 10:01pm ET

Galena Biopharma Inc (NASDAQ:GALE)

1.64
Delayed Data
As of Jul 31
 -0.02 / -1.20%
Today’s Change
1.27
Today|||52-Week Range
3.16
+8.61%
Year-to-Date
No recent news for Galena Biopharma Inc.

Today’s Trading

Previous close1.66
Today’s open1.63
Day’s range1.62 - 1.66
Volume1,118,579
Average volume (3 months)3,167,901
Market cap$260.4M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+63.53%
Earnings growth (this year)-7.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+274.71%
P/E ratioNM
Price/Sales19.35
Price/Book5.62

Competitors

 Today’s
change
Today’s
% change
NAVBNavidea Biopharmaceu...+0.02+1.18%
NVLSNivalis Therapeutics...-0.43-2.47%
DRNADicerna Pharmaceutic...+0.20+1.66%
PPHMPeregrine Pharmaceut...-0.02-1.60%
Data as of 4:11pm ET, 07/31/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$9.3M
Annual profit (last year)-$36.6M
Net profit margin-392.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
Portland, Oregon

Forecasts